Exploring PRM-A as a novel glycan-targeted therapy for SARS-CoV-2 inhibition
HIV, Ebola and most recently, COVID-19 viruses have had an enormous impact on our societies world-wide. All these viruses are ...
HIV, Ebola and most recently, COVID-19 viruses have had an enormous impact on our societies world-wide. All these viruses are ...
Researchers from the London School of Hygiene & Tropical Medicine (LSHTM) have been awarded £2m funding through the UK Research ...
In a recent article published in Proceedings of the National Academy of Sciences, researchers evaluate the potency of antiviral lectins against ...
MIT researchers have identified molecules found in mucus that can block cholera infection by interfering with the genes that cause ...
In a recent study published in the journal Advanced Science, researchers developed molecularly imprinted nanoparticles (nanoMIPs) with broad-spectrum activity against ...
A recent study published in Science Advances showed that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Spike N-glycosylation patterns, intracellular lectins, as ...
In a recent study published in the Advanced Science journal, researchers assessed the effectiveness of synthetic mucin gels in the ...
A recent study posted on the bioRxiv* preprint server explored the glycan shield diversity of sarbecoviruses, furthering the knowledge for ...
In a recent article published in the bioRxiv* preprint server, researchers explored how the natural alterations inside the severe acute respiratory ...
A cytokine named TRAIL binds to TRAIL receptors and kills cancer cells, but not normal cells. Therefore, various anticancer drugs ...
Sepoy.net is a perfect place for people who want daily updates on news related to business, technology, entertainment, health, cryptocurrency etc.
Contact: hello@sepoy.net
© 2023 Sepoy.net